FDA Approves Remdesivir To Treat Patients With COVID-19, Severe Renal Impairment

Healio (7/14, Carter) reported that the FDA has approved the use of Gilead Science’s Veklury (remdesivir) “for the treatment of COVID-19 in patients with severe renal impairment, including those on dialysis.”